Funding
Boundless Bio Raises Fresh Capital to Boost extrachromosomal DNA Targeting Therapeutic Efforts
2021-04-30
With $41.9 Million from Oversubscribed Financing Round, XyloCor Sets Sights on Gene Therapy for Heart Disease
2021-03-23
With $74 Million in Fresh Capital, Belgian Startup Aims to Advance its Regenerative Pathway Modulators
2021-03-11
Massachusetts Cancer Startup to Fund Mission of Drugging the Undruggable with $107M Series C Round
2021-03-07
Looking to Overcome Limitations in Gene Therapy Space, PBM Capital Backed Startup Launches with $20 M in Series A
2021-03-02
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02